Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 1.38 -1.43% -0.02
MRNS closed down 1.43 percent on Wednesday, October 16, 2019, on 33 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRNS trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish -1.43%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.43%
Narrow Range Bar Range Contraction -1.43%
Stochastic Reached Oversold Weakness -1.43%
Inside Day Range Contraction -1.43%
Oversold Stochastic Weakness -1.43%
50 DMA Support Bullish -0.72%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.72%

Older signals for MRNS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Chemistry Physical Sciences Drugs Alcohols Ketones Pregnanes Sedatives Neurosteroids
Is MRNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.27
52 Week Low 0.77
Average Volume 1,529,338
200-Day Moving Average 3.1978
50-Day Moving Average 1.3906
20-Day Moving Average 1.4305
10-Day Moving Average 1.417
Average True Range 0.1337
ADX 20.2
+DI 26.0263
-DI 20.1518
Chandelier Exit (Long, 3 ATRs ) 1.5989
Chandelier Exit (Short, 3 ATRs ) 1.6611
Upper Bollinger Band 1.5945
Lower Bollinger Band 1.2665
Percent B (%b) 0.35
BandWidth 22.929046
MACD Line -0.0402
MACD Signal Line -0.0376
MACD Histogram -0.0027
Fundamentals Value
Market Cap 35.98 Million
Num Shares 26.1 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.49
Resistance 3 (R3) 1.49 1.45 1.47
Resistance 2 (R2) 1.45 1.43 1.45 1.46
Resistance 1 (R1) 1.42 1.41 1.40 1.42 1.46
Pivot Point 1.38 1.38 1.38 1.38 1.38
Support 1 (S1) 1.35 1.36 1.33 1.35 1.30
Support 2 (S2) 1.31 1.34 1.31 1.30
Support 3 (S3) 1.28 1.31 1.29
Support 4 (S4) 1.28